LYELL IMMUNOPHARMA INC (LYEL): Ownership & Insider Activity

Hedge funds and institutional managers reporting a position in LYEL · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
10
13F filers
Aggregate Value
$12.3M
Across holders
Last Price
$14.74
2026-08-24
Sector
Health Care
GICS
Quarterly fund activity5 increased5 reduced0 exited
Institutional Holders of LYEL
10 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
MILLENNIUM MANAGEMENT LLC
CIK 0001273087
Hedge Fund367K$5.2M41.9%0.0%Reduced$-1.3MQ2 2026
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund130K$1.8M14.9%0.0%Added+$194KQ2 2026
Qube Research & Technologies Ltd
CIK 0001729829
Hedge Fund111K$1.6M12.6%0.0%Added+$779KQ2 2026
MARSHALL WACE, LLP
CIK 0001318757
Hedge Fund106K$1.5M12.1%0.0%Reduced$-196KQ2 2026
TWO SIGMA INVESTMENTS, LP
CIK 0001179392
Hedge Fund53K$744K6.0%0.0%Added+$581KQ2 2026
Squarepoint Ops LLC
CIK 0001642575
Hedge Fund42K$595K4.8%0.0%Added+$324KQ2 2026
Point72 Asset Management, L.P.
CIK 0001603466
Hedge Fund26K$366K3.0%0.0%Added+$67KQ2 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund19K$263K2.1%0.0%Reduced+$94KQ2 2026
Brevan Howard Capital Management LP
CIK 0001512857
Hedge Fund12K$162K1.3%0.0%Reduced$-26KQ2 2026
Walleye Capital LLC
CIK 0001758720
Hedge Fund10K$147K1.2%0.0%Reduced$-165KQ2 2026
Loading recent insider activity…